AbCellera Biologics
ABCL
ABCL
143 hedge funds and large institutions have $370M invested in AbCellera Biologics in 2025 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 49 increasing their positions, 38 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.37% more ownership
Funds ownership: 34.81% → 36.18% (+1.4%)
29% less capital invested
Capital invested by funds: $525M → $370M (-$154M)
Holders
143
Holding in Top 10
–
Calls
$7.01M
Puts
$3.07M
Top Buyers
| 1 | +$35.2M | |
| 2 | +$18.3M | |
| 3 | +$9.13M | |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$4.76M |
| 5 |
Jane Street
New York
|
+$4.46M |
Top Sellers
| 1 | -$52.4M | |
| 2 | -$13.1M | |
| 3 | -$4.34M | |
| 4 |
DnB Asset Management
Oslo,
Norway
|
-$3.3M |
| 5 |
Millennium Management
New York
|
-$2.93M |
